Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xos (XOS) Research & Development (2020 - 2025)

Xos (XOS) has disclosed Research & Development for 6 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • For Q4 2025, Research & Development fell 2.79% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $8.0 million, down 24.72%, while the annual FY2025 figure was $8.0 million, 24.72% down from the prior year.
  • Research & Development was $1.9 million for Q4 2025 at Xos, down from $2.1 million in the prior quarter.
  • The five-year high for Research & Development was $8.6 million in Q3 2022, with the low at $1.9 million in Q4 2025.
  • Historically, Research & Development has averaged $4.3 million across 5 years, with a median of $4.2 million in 2021.
  • The largest annual shift saw Research & Development soared 946.22% in 2021 before it plummeted 53.27% in 2024.
  • Over 5 years, Research & Development stood at $4.3 million in 2021, then surged by 43.16% to $6.2 million in 2022, then tumbled by 33.03% to $4.1 million in 2023, then plummeted by 53.27% to $1.9 million in 2024, then fell by 2.79% to $1.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $1.9 million in Q4 2025, $2.1 million in Q3 2025, and $2.1 million in Q2 2025.